Rapid Detection.
Targeted Treatment.
Improved Outcomes.
Reduced Cost.
We are transforming the detection of sepsis-causing pathogens and AMR. Broad pathogen ID in 30 minutes and phenotypic AST in 3 hours, compared to 2+ days.
Built for change.
Born at Oxford
Backed by Science
Built to Save Time.
Designed to Improve Outcomes.
Every hour without the right treatment increases a patient’s risk of death.
Yet today’s diagnostics continue to depend on blood culture results, which take 2-3 days.
At Vivid Dx, we’ve reimagined the process from the ground up — creating a next-generation diagnostics platform to detect a broad number of sepsis-causing pathogens in 30 minutes and delivers phenotypic antimicrobial susceptibility (AST) results in just 3 hours.
No blood culture.
No delay.
Next-Generation Diagnostics for Sepsis and AMR
Vivid Dx unites leading experts in spectroscopy and microbiology with seasoned diagnostics executives to deliver a category-defining platform.
We are developing a next-generation diagnostic platform that reads the biochemical fingerprint of single cells using Raman spectroscopy, detects sepsis-causing pathogens using a large, proprietary Raman spectra database, and accelerates detection through the use of advanced Artificial Intelligence and Machine Learning. The result: faster, broader, and more actionable diagnostics, directly from blood.